BWXT Medical submits Tc-99m generator application to FDA

September 14, 2022, 3:02PMNuclear News

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.

To continue reading, log in or create a free account!

Related Articles

Beyond the grid

April 21, 2026, 11:54AMNuclear NewsCraig Piercy

In this month’s issue of Nuclear News, readers will find coverage of the “other” areas where nuclear technology is pushing into new frontiers. From marine nuclear propulsion to nuclear...

Supporting ANS now, for the future

March 18, 2026, 10:03AMNuclear NewsHash Hashemian

From kindergarten classrooms to national security facilities, each event I attended during the opening weeks of the new year underscored one truth: The future of nuclear energy depends on the...

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Saskatchewan expands its nuclear plans

January 30, 2026, 12:21PMNuclear News

This week, the government of Saskatchewan, alongside electric utility SaskPower, announced plans to formally evaluate the deployment of large nuclear technologies. This process will take place...